Therapeutic IVT RNA

VectorBuilder offers a comprehensive platform for the development of RNA therapeutics including vaccines, gene replacement, chimeric antigen receptor (CAR), and gene editing. Leveraging our extensive design and production experience with premade and custom RNAs, our team can support in vitro transcription (IVT) RNA synthesis and lipid nanoparticle (LNP) encapsulation for a variety of RNA-based expression systems. Researchers can accelerate the development of their RNA therapeutics with our CRO services, offering in vitro and in vivo candidate screening and functional testing.

Highlights

Comprehensive Platform Offering research and clinical grades of RNA, a variety of RNA systems, customizable IVT RNA production and LNP encapsulation, and a full suite of CRO and CDMO services

Experts in RNA Development Our team comprises scientists with expertise of the full scope of considerations for therapeutic IVT vector design, sequence optimization and screening, and process development

Highest Quality and Consistency State-of-the-art facilities and equipment providing the highest purity and consistency, ensured by a full panel of quality control assays